Stilboestrol and stuttering priapism in homozygous sickle-cell disease

Lancet. 1985 Dec 7;2(8467):1274-6. doi: 10.1016/s0140-6736(85)91555-7.

Abstract

A double-blind, placebo-controlled crossover study was conducted in 11 patients with stuttering attacks of priapism and homozygous sickle-cell (SS) disease. Stilboestrol 5 mg daily was better than the placebo in preventing attacks.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Anemia, Sickle Cell / complications*
  • Clinical Trials as Topic
  • Diethylstilbestrol / therapeutic use*
  • Double-Blind Method
  • Humans
  • Male
  • Priapism / drug therapy*
  • Priapism / etiology
  • Priapism / prevention & control
  • Random Allocation
  • Recurrence

Substances

  • Diethylstilbestrol